Early Access — free while we kick the tires
EdgarHawk

Samaha Eli

Director

Director 10% Owner
3 filings analyzed · 2 companies · Latest 2025-06-06

Companies

Company Buys Sells Direction
Stagwell Inc STGW 3 0 Net buying
Theravance Biopharma, Inc. TBPH 1 0 Net buying

Activity

June 2025
2025-06-06 Stagwell Inc STGW
medium
Buy
665,757 shares
$2,881,182
Significance 6/10

Director Samaha Eli bought 665,757 shares across two transactions totaling $2,881,182.39 at Stagwell Inc (STGW) on 2025-06-04 and 2025-06-05.

Director Samaha Eli purchased 665,757 shares across 2 transactions totaling $2,881,182.39 (at blended average $4.33), increasing his holdings by 9.1% from 7,348,565 to 8,014,322 shares. The stock has declined 22.7% over the past 30 days and 27.9% over 90 days, trading at $4.49 versus a 52-week high of $8.10, placing it 44.6% below peak levels. This filing coincides with a cluster pattern: 2 other insiders also bought within the past 14 days. Critically, Samaha's cross-ticker track record shows 16 prior buys with a 93.33% 90-day win rate (average +61.6% return), but his prior STGW buy on 2025-05-09 remains too recent for outcome measurement, leaving no same-ticker timing history. Fundamentals show revenue of $651,740,000.00 (+12.4% annual growth) against a net loss of $-2,917,000.00 in the latest quarter, and market cap of $1,201,895,480.15.

May 2025
2025-05-13 Stagwell Inc STGW
medium
Buy
200,903 shares
$956,318
Significance 6/10

Director Samaha Eli bought 200,903 shares of STGW at $4.76, adding $956,318.37 to position near 52-week low.

Director Eli Samaha purchased 200,903 shares at $4.76, representing a $956.3K capital deployment that increased his holdings by 2.8% to 7.35M shares. The purchase occurred at a price 13% below the current $5.41 level and 41% below the 52-week high of $8.10, placing the transaction near depressed valuation territory. Samaha's cross-ticker open-market history shows 16 prior buys with an average 90-day return of +62.8% (win rate 93.75%), but this backward-looking track record does not constrain forward outcomes at this ticker; notably, his cross-ticker sells have demonstrated a 0.00% well-timed rate, indicating systematic difficulty timing sell exits. STGW fundamentals show net losses of $2.9M against revenue of $651.7M with annual growth of +12.4%, creating a mixed picture: growth on the top line coupled with near-term profitability headwinds.

August 2024
high
Buy
999,800 shares
$7,798,440
Significance 7/10

10% owner Samaha Eli purchased 999,800 shares of TBPH at $7.80 for $7.8M, expanding stake to 9.51M shares despite stock down 33.9% from 52-week high.

Samaha Eli, a 10% shareholder, deployed $7,798,440.00 to acquire 999,800 shares at $7.80 on 2024-08-07, increasing his position by 11.7% to 9,511,150 shares. The timing aligns with a stock price under pressure: the current price of $7.66 reflects a -33.9% decline from the 52-week high of $11.59 and a -13.2% drop over the prior 30 days, signaling execution during a period of weakness. The company's fundamentals show ongoing challenges—annual revenue of $14,256,000.00 for the latest quarter with a net loss of $-16,529,000.00, and full-year net income was negative despite 11.8% annual revenue growth. Notably, Samaha's prior two purchases at this ticker (both on 2024-05-01) each achieved 15.0% gains at the 90-day mark, suggesting a pattern of well-timed entry points at this specific stock, though his cross-ticker track record shows broader strength with 16 prior buys averaging +21.3% 30d returns and +68.0% 90d returns at 100% win rate.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access